Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board

Neurooncol Adv. 2022 Jun 14;4(1):vdac092. doi: 10.1093/noajnl/vdac092. eCollection 2022 Jan-Dec.
No abstract available

Keywords: RB1; intrathecal topotecan; metronomic therapy; pineoblastoma.